Medsilo Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 5.00 M
- Revenue Growth -38.91%
- Profit Growth -564.68%
- Ebitda -36.41%
- Net Worth -149.57%
- Total Assets -41.33%
About Medsilo Pharmaceuticals
Medsilo Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 July 2014 and has a history of Ten years and six months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.00 M.
Ravikumar Saranlal and Santhanam Alexander serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74900TN2014PTC096613
- Company No.
096613
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jul 2014
- Date of AGM
26 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
What products or services does Medsilo Pharmaceuticals Private Limited offer?
Medsilo Pharmaceuticals Private Limited offers a wide range of products and services, including Allopathic Cough Syrup, Benadryl Cough Syrup, Mineral Supplement, Calcium Tablet.
Who are the key members and board of directors at Medsilo Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravikumar Saranlal  | Director | 21-Jul-2014 | Current |
| Santhanam Alexander | Director | 21-Jul-2014 | Current |
Financial Performance of Medsilo Pharmaceuticals.
Medsilo Pharmaceuticals Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 38.91% decrease. The company also saw a substantial fall in profitability, with a 564.68% decrease in profit. The company's net worth observed a substantial decline by a decrease of 149.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medsilo Pharmaceuticals?
In 2018, Medsilo Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shrusti Foundations India Private LimitedSanthanam Alexander is a mutual person
- Maximax Engineering Consultants Private Limited
Santhanam Alexander is a mutual person
Charges (Loans)
₹5.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of Travancore : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Mar 2015 | State Bank Of Travancore | ₹5.00 M | Open |
How Many Employees Work at Medsilo Pharmaceuticals?
Unlock and access historical data on people associated with Medsilo Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medsilo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medsilo Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
